NAMS reports Wednesday, Nov 4, 2026, before the open. After the last 4 reports the stock moved −0.5%, +12.5%, +1.5%, +4.4% the next day.
NAMS is expected to report on Wednesday, Nov 4, 2026, before the open (US Eastern time).
| Report | EPS est. | EPS | Next day | Week |
|---|---|---|---|---|
| Aug 5, 2026 | -0.43 | -0.45 | −0.5% | +0.3% |
| May 7, 2026 | -0.41 | -0.34 | +12.5% | +21.8% |
| Feb 18, 2026 | -0.37 | -0.53 | +1.5% | +2.2% |
| Nov 5, 2025 | -0.34 | -0.53 | +4.4% | +9.2% |
| Aug 6, 2025 | -0.43 | -0.13 | +8.7% | +15.0% |
| May 8, 2025 | -0.44 | -0.30 | +1.8% | −0.9% |
| Feb 26, 2025 | -0.47 | -0.90 | +10.2% | +20.2% |
| Nov 6, 2024 | -0.45 | -0.16 | +13.7% | +29.3% |
Average move the next trading day over the last 8 reports: ±6.7% (7 of 8 up).
NAMS is in a downtrend, momentum firm. $20 is the level overhead; $19.53 the first support below.
NAMS at $19.97. Nearest resistance $20.00 (+0.2%). Nearest support $19.53 (−2.2%).
NAMS chart, levels and analysis · Latest analysis: NewAmsterdam Pharma Company N.V (NAMS) stock analysis, October 8, 2026: NAMS breaks $21.86 support, now at $21.10 with no news to explain the slide · Earnings this week
NAMS is expected to report on Wednesday, Nov 4, 2026, before the open.
NAMS reports before the open, US Eastern time.
After its report on Aug 5, 2026, NAMS moved −0.5% the next trading day.
Over the last 8 reports, NAMS moved 6.7% on average the next trading day, up 7 times out of 8.